Listed

Cingulate Inc.

CINGNasdaqCIK 1862150HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$5.4m, Q2 FY2026
Net income−$5.9m, Q2 FY2026
Cingulate Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$k3,924Research and development, Q3 FY2023, three months to 2023-09-30$3.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001493152-24-043916.Report this figure4,985Research and development, Q4 FY2023, three months to 2023-12-31$5.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-27, accession 0001641172-25-000970. Derived: 12-month figure less the 9-month figure.Report this figure1,807Research and development, Q1 FY2024, three months to 2024-03-31$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001641172-25-009289.Report this figure1,881Research and development, Q2 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-19, accession 0001641172-25-024744.Report this figure1,429Research and development, Q3 FY2024, three months to 2024-09-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure4,329Research and development, Q4 FY2024, three months to 2024-12-31$4.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-18, accession 0001493152-26-010882. Derived: 12-month figure less the 9-month figure.Report this figure2,223Research and development, Q1 FY2025, three months to 2025-03-31$2.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure2,701Research and development, Q2 FY2025, three months to 2025-06-30$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure2,849Research and development, Q3 FY2025, three months to 2025-09-30$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure2,002Research and development, Q4 FY2025, three months to 2025-12-31$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-18, accession 0001493152-26-010882. Derived: 12-month figure less the 9-month figure.Report this figure2,184Research and development, Q1 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure1,487Research and development, Q2 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure
Selling, general and administrative$knot reportednot reportednot reportednot reportednot reportednot reportednot reported1,949Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$1.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figurenot reportednot reportednot reported3,928Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$3.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure
Operating income$k(5,750)Operating income, Q3 FY2023, three months to 2023-09-30−$5.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001493152-24-043916.Report this figure(6,797)Operating income, Q4 FY2023, three months to 2023-12-31−$6.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-27, accession 0001641172-25-000970. Derived: 12-month figure less the 9-month figure.Report this figure(2,948)Operating income, Q1 FY2024, three months to 2024-03-31−$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001641172-25-009289.Report this figure(3,206)Operating income, Q2 FY2024, three months to 2024-06-30−$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-19, accession 0001641172-25-024744.Report this figure(3,282)Operating income, Q3 FY2024, three months to 2024-09-30−$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure(6,208)Operating income, Q4 FY2024, three months to 2024-12-31−$6.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-18, accession 0001493152-26-010882. Derived: 12-month figure less the 9-month figure.Report this figure(3,706)Operating income, Q1 FY2025, three months to 2025-03-31−$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure(4,650)Operating income, Q2 FY2025, three months to 2025-06-30−$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure(5,996)Operating income, Q3 FY2025, three months to 2025-09-30−$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure(5,586)Operating income, Q4 FY2025, three months to 2025-12-31−$5.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-18, accession 0001493152-26-010882. Derived: 12-month figure less the 9-month figure.Report this figure(7,923)Operating income, Q1 FY2026, three months to 2026-03-31−$7.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure(5,415)Operating income, Q2 FY2026, three months to 2026-06-30−$5.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure
Interest expense$k238Interest expense, Q3 FY2023, three months to 2023-09-30$237.5k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-13, accession 0001493152-23-040540.Report this figure113Interest expense, Q4 FY2023, three months to 2023-12-31$112.5k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-04-01, accession 0001493152-24-012159. Derived: 12-month figure less the 9-month figure.Report this figure31.3Interest expense, Q1 FY2024, three months to 2024-03-31$31.3k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-08, accession 0001493152-24-018159.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$k(5,979)Net income, Q3 FY2023, three months to 2023-09-30−$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001493152-24-043916.Report this figure(6,935)Net income, Q4 FY2023, three months to 2023-12-31−$6.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-27, accession 0001641172-25-000970. Derived: 12-month figure less the 9-month figure.Report this figure(2,972)Net income, Q1 FY2024, three months to 2024-03-31−$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure(3,230)Net income, Q2 FY2024, three months to 2024-06-30−$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure(4,126)Net income, Q3 FY2024, three months to 2024-09-30−$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure(6,231)Net income, Q4 FY2024, three months to 2024-12-31−$6.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-18, accession 0001493152-26-010882. Derived: 12-month figure less the 9-month figure.Report this figure(3,853)Net income, Q1 FY2025, three months to 2025-03-31−$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure(4,983)Net income, Q2 FY2025, three months to 2025-06-30−$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure(7,341)Net income, Q3 FY2025, three months to 2025-09-30−$7.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure(6,273)Net income, Q4 FY2025, three months to 2025-12-31−$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-18, accession 0001493152-26-010882. Derived: 12-month figure less the 9-month figure.Report this figure(9,312)Net income, Q1 FY2026, three months to 2026-03-31−$9.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure(5,870)Net income, Q2 FY2026, three months to 2026-06-30−$5.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure
Diluted EPS$ per share(72.60)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$72.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001493152-24-043916.Report this figurenot reported(7.21)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$7.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001641172-25-009289.Report this figure(5.47)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$5.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-19, accession 0001641172-25-024744.Report this figure(2.34)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$2.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figurenot reported(1.06)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure(1.14)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure(1.35)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figurenot reported(0.95)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure(0.45)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure
Basic EPS$ per share(72.60)Basic EPS, Q3 FY2023, three months to 2023-09-30−$72.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001493152-24-043916.Report this figurenot reported(7.21)Basic EPS, Q1 FY2024, three months to 2024-03-31−$7.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001641172-25-009289.Report this figure(5.47)Basic EPS, Q2 FY2024, three months to 2024-06-30−$5.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-19, accession 0001641172-25-024744.Report this figure(2.34)Basic EPS, Q3 FY2024, three months to 2024-09-30−$2.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figurenot reported(1.06)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure(1.14)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure(1.35)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figurenot reported(0.95)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.95 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure(0.45)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure

Balance sheet

Cash and equivalents$28.4m, Q2 FY2026
Shareholders' equity$23.5m, Q2 FY2026
Cingulate Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m2.0Cash and equivalents, Q3 FY2023, at 2023-09-30$2.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001493152-23-040540.Report this figure0.1Cash and equivalents, FY2023, at 2023-12-31$52.4k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-27, accession 0001641172-25-000970.Report this figure1.1Cash and equivalents, Q1 FY2024, at 2024-03-31$1.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0001493152-24-018159.Report this figure0.4Cash and equivalents, Q2 FY2024, at 2024-06-30$380.9k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0001493152-24-031469.Report this figure10.0Cash and equivalents, Q3 FY2024, at 2024-09-30$10.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001493152-24-043916.Report this figure12.2Cash and equivalents, FY2024, at 2024-12-31$12.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-18, accession 0001493152-26-010882.Report this figure9.5Cash and equivalents, Q1 FY2025, at 2025-03-31$9.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001641172-25-009289.Report this figure8.9Cash and equivalents, Q2 FY2025, at 2025-06-30$8.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-19, accession 0001641172-25-024744.Report this figure6.1Cash and equivalents, Q3 FY2025, at 2025-09-30$6.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure11.0Cash and equivalents, FY2025, at 2025-12-31$11.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure25.9Cash and equivalents, Q1 FY2026, at 2026-03-31$25.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure28.4Cash and equivalents, Q2 FY2026, at 2026-06-30$28.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure
Current assets$m2.9Current assets, Q3 FY2023, at 2023-09-30$2.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001493152-23-040540.Report this figure0.6Current assets, FY2023, at 2023-12-31$578.6k. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-27, accession 0001641172-25-000970.Report this figure2.7Current assets, Q1 FY2024, at 2024-03-31$2.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001493152-24-018159.Report this figure2.5Current assets, Q2 FY2024, at 2024-06-30$2.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001493152-24-031469.Report this figure11.3Current assets, Q3 FY2024, at 2024-09-30$11.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001493152-24-043916.Report this figure12.7Current assets, FY2024, at 2024-12-31$12.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-18, accession 0001493152-26-010882.Report this figure10.5Current assets, Q1 FY2025, at 2025-03-31$10.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001641172-25-009289.Report this figure10.2Current assets, Q2 FY2025, at 2025-06-30$10.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-19, accession 0001641172-25-024744.Report this figure7.4Current assets, Q3 FY2025, at 2025-09-30$7.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure12.0Current assets, FY2025, at 2025-12-31$12.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure27.9Current assets, Q1 FY2026, at 2026-03-31$27.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure30.2Current assets, Q2 FY2026, at 2026-06-30$30.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure
Total assets$m5.9Total assets, Q3 FY2023, at 2023-09-30$5.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001493152-23-040540.Report this figure3.5Total assets, FY2023, at 2023-12-31$3.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-27, accession 0001641172-25-000970.Report this figure5.5Total assets, Q1 FY2024, at 2024-03-31$5.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001493152-24-018159.Report this figure5.1Total assets, Q2 FY2024, at 2024-06-30$5.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001493152-24-031469.Report this figure13.6Total assets, Q3 FY2024, at 2024-09-30$13.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001493152-24-043916.Report this figure14.9Total assets, FY2024, at 2024-12-31$14.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-18, accession 0001493152-26-010882.Report this figure12.5Total assets, Q1 FY2025, at 2025-03-31$12.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001641172-25-009289.Report this figure13.5Total assets, Q2 FY2025, at 2025-06-30$13.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-19, accession 0001641172-25-024744.Report this figure10.5Total assets, Q3 FY2025, at 2025-09-30$10.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure15.1Total assets, FY2025, at 2025-12-31$15.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure30.9Total assets, Q1 FY2026, at 2026-03-31$30.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure33.1Total assets, Q2 FY2026, at 2026-06-30$33.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure
Current liabilities$m5.7Current liabilities, Q3 FY2023, at 2023-09-30$5.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001493152-23-040540.Report this figure10.2Current liabilities, FY2023, at 2023-12-31$10.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-27, accession 0001641172-25-000970.Report this figure2.2Current liabilities, Q1 FY2024, at 2024-03-31$2.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001493152-24-018159.Report this figure2.0Current liabilities, Q2 FY2024, at 2024-06-30$2.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001493152-24-031469.Report this figure1.5Current liabilities, Q3 FY2024, at 2024-09-30$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001493152-24-043916.Report this figure5.0Current liabilities, FY2024, at 2024-12-31$5.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-18, accession 0001493152-26-010882.Report this figure5.6Current liabilities, Q1 FY2025, at 2025-03-31$5.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001641172-25-009289.Report this figure6.7Current liabilities, Q2 FY2025, at 2025-06-30$6.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-19, accession 0001641172-25-024744.Report this figure5.9Current liabilities, Q3 FY2025, at 2025-09-30$5.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure10.3Current liabilities, FY2025, at 2025-12-31$10.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure11.0Current liabilities, Q1 FY2026, at 2026-03-31$11.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure8.6Current liabilities, Q2 FY2026, at 2026-06-30$8.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure
Total liabilities$m6.0Total liabilities, Q3 FY2023, at 2023-09-30$6.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001493152-23-040540.Report this figure10.4Total liabilities, FY2023, at 2023-12-31$10.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-27, accession 0001641172-25-000970.Report this figure2.3Total liabilities, Q1 FY2024, at 2024-03-31$2.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0001493152-24-018159.Report this figure2.0Total liabilities, Q2 FY2024, at 2024-06-30$2.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001493152-24-031469.Report this figure1.5Total liabilities, Q3 FY2024, at 2024-09-30$1.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001493152-24-043916.Report this figure7.4Total liabilities, FY2024, at 2024-12-31$7.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-18, accession 0001493152-26-010882.Report this figure6.5Total liabilities, Q1 FY2025, at 2025-03-31$6.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001641172-25-009289.Report this figure8.0Total liabilities, Q2 FY2025, at 2025-06-30$8.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-19, accession 0001641172-25-024744.Report this figure7.0Total liabilities, Q3 FY2025, at 2025-09-30$7.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure12.6Total liabilities, FY2025, at 2025-12-31$12.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure12.0Total liabilities, Q1 FY2026, at 2026-03-31$12.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure9.6Total liabilities, Q2 FY2026, at 2026-06-30$9.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure
Shareholders' equity$m(0.1)Shareholders' equity, Q3 FY2023, at 2023-09-30−$96.3k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001493152-24-043916.Report this figure(6.9)Shareholders' equity, FY2023, at 2023-12-31−$6.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-18, accession 0001493152-26-010882.Report this figure3.2Shareholders' equity, Q1 FY2024, at 2024-03-31$3.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure3.1Shareholders' equity, Q2 FY2024, at 2024-06-30$3.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure12.0Shareholders' equity, Q3 FY2024, at 2024-09-30$12.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure7.5Shareholders' equity, FY2024, at 2024-12-31$7.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure5.9Shareholders' equity, Q1 FY2025, at 2025-03-31$5.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure5.5Shareholders' equity, Q2 FY2025, at 2025-06-30$5.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure3.5Shareholders' equity, Q3 FY2025, at 2025-09-30$3.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure2.5Shareholders' equity, FY2025, at 2025-12-31$2.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure18.9Shareholders' equity, Q1 FY2026, at 2026-03-31$18.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure23.5Shareholders' equity, Q2 FY2026, at 2026-06-30$23.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure

Cash flow

Operating cash flow−$5.9m, Q2 FY2026
Capital expenditure$67.1k, Q2 FY2026
Cingulate Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(4,292)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001493152-24-043916. Derived: 9-month figure less the 6-month figure.Report this figure(2,562)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$2.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-27, accession 0001641172-25-000970. Derived: 12-month figure less the 9-month figure.Report this figure(8,746)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$8.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001641172-25-009289.Report this figure(1,742)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-19, accession 0001641172-25-024744. Derived: 6-month figure less the 3-month figure.Report this figure(3,883)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001493152-25-022395. Derived: 9-month figure less the 6-month figure.Report this figure(4,080)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$4.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-18, accession 0001493152-26-010882. Derived: 12-month figure less the 9-month figure.Report this figure(4,608)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure(4,795)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001493152-26-037606. Derived: 6-month figure less the 3-month figure.Report this figure(4,244)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001493152-25-022395. Derived: 9-month figure less the 6-month figure.Report this figure(3,597)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$3.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-18, accession 0001493152-26-010882. Derived: 12-month figure less the 9-month figure.Report this figure(6,913)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$6.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure(5,900)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$5.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001493152-26-037606. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001493152-24-043916. Derived: 9-month figure less the 6-month figure.Report this figure187Capital expenditure, Q4 FY2023, three months to 2023-12-31$187.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-27, accession 0001641172-25-000970. Derived: 12-month figure less the 9-month figure.Report this figure81.5Capital expenditure, Q1 FY2024, three months to 2024-03-31$81.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001641172-25-009289.Report this figure72.6Capital expenditure, Q2 FY2024, three months to 2024-06-30$72.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-19, accession 0001641172-25-024744. Derived: 6-month figure less the 3-month figure.Report this figure(141)Capital expenditure, Q3 FY2024, three months to 2024-09-30−$140.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001493152-25-022395. Derived: 9-month figure less the 6-month figure.Report this figure198Capital expenditure, Q4 FY2024, three months to 2024-12-31$198.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-18, accession 0001493152-26-010882. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001493152-25-022395. Derived: 9-month figure less the 6-month figure.Report this figure156Capital expenditure, Q4 FY2025, three months to 2025-12-31$156.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-18, accession 0001493152-26-010882. Derived: 12-month figure less the 9-month figure.Report this figure61.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$61.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure67.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$67.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001493152-26-037606. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)13.19m, Q2 FY2026
Cingulate Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares11.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3011,309,412 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001493152-23-040540.Report this figure0.6Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31565,471 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001493152-24-018159.Report this figure1.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30974,569 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001493152-24-031469.Report this figure0.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3082,361 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001493152-24-043916.Report this figure0.4Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31412,126 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001641172-25-009289.Report this figure0.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30586,313 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-19, accession 0001641172-25-024744.Report this figure1.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-301,766,362 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure3.6Diluted shares (weighted), Q1 FY2025, three months to 2025-03-313,646,893 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure4.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-304,389,465 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure5.4Diluted shares (weighted), Q3 FY2025, three months to 2025-09-305,431,206 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001493152-25-022395.Report this figure9.8Diluted shares (weighted), Q1 FY2026, three months to 2026-03-319,777,786 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001493152-26-022884.Report this figure13.2Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3013,186,057 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure

Shares outstanding: 14.54mShares outstanding, period not labelled, at 2026-08-1214,541,826 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037606.Report this figure at Aug 12, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.